Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Int J Pharm ; 564: 492-498, 2019 Jun 10.
Artículo en Inglés | MEDLINE | ID: mdl-31022505

RESUMEN

The present study aimed to develop a photochemically stabilized formulation of dacarbazine [5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide; DTIC] for reducing the production of algogenic photodegradant (5-diazoimidazole-4-carboxamide; Diazo-IC). Photochemical properties of DTIC were characterized by UV-visible light spectral analysis, reactive oxygen species (ROS) assay, and photostability testing. A pharmacokinetic study was conducted after intravenous administration of DTIC formulations (1 mg-DTIC/kg) to rats. DTIC exhibited strong absorption in the UVA range, and photoirradiated DTIC exhibited marked ROS generation. Thus, DTIC had high photoreactive potential. After exposure of DTIC (1 mM) to simulated sunlight (250 W/m2) for 3 min, remaining DTIC and yielded Diazo-IC were estimated to be ca. 230 µM and 600 µM, respectively. The addition of radical scavenger (1 mM), including l-ascorbic acid, l-cysteine (Cys), l-histidine, D-mannitol, l-tryptophan, or l-tyrosine, to DTIC (1 mM) could attenuate DTIC photoreactions, and in particular, the addition of Cys to DTIC brought ca. 34% and 86% inhibition of DTIC photodegradation and Diazo-IC photogeneration, respectively. There were no significant differences in the calculated pharmacokinetic parameters of DTIC between DTIC and DTIC with Cys (0.67 mg/kg). From these findings, the supplementary use of Cys would be an effective approach to improve the photostability of DTIC with less production of Diazo-IC.


Asunto(s)
Antineoplásicos Alquilantes , Compuestos Azo/química , Cisteína/química , Dacarbazina , Depuradores de Radicales Libres/química , Imidazoles/química , Luz , Animales , Antineoplásicos Alquilantes/sangre , Antineoplásicos Alquilantes/química , Antineoplásicos Alquilantes/farmacocinética , Antineoplásicos Alquilantes/efectos de la radiación , Dacarbazina/sangre , Dacarbazina/química , Dacarbazina/farmacocinética , Dacarbazina/efectos de la radiación , Estabilidad de Medicamentos , Masculino , Fotólisis , Ratas Sprague-Dawley
2.
J Control Release ; 210: 95-104, 2015 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-25982679

RESUMEN

Glioblastoma is the most frequent primary malignant brain tumor in adults. Despite treatments including surgery, radiotherapy and chemotherapy by oral Temozolomide (TMZ), the prognosis of patients with glioblastoma remains very poor. We hypothesized that a polyethylene glycol dimethacrylate (PEG-DMA) injectable hydrogel would provide a sustained and local delivery of TMZ. The hydrogel photopolymerized rapidly (<2min) and presented a viscous modulus (≈10kPa). TMZ release kinetic presented two phases: a linear burst release of 45% of TMZ during the first 24h, followed by a logarithmic release of 20% over the first week. The in vivo tolerability study showed that the unloaded hydrogel did not induce apoptosis in mice brains nor increased microglial activation. In vivo, the anti-tumor efficacy of TMZ-hydrogel was evaluated on xenograft U87MG tumor-bearing nude mice. The tumor weight of mice treated with the photopolymerized TMZ hydrogel drastically decreased compared with all other groups. Higher apoptosis (located at the center of the tumor) was also observed. The present study demonstrates the potential of a photopolymerizable TMZ-loaded hydrogel to treat glioblastoma.


Asunto(s)
Antineoplásicos Alquilantes/administración & dosificación , Neoplasias Encefálicas/tratamiento farmacológico , Dacarbazina/análogos & derivados , Sistemas de Liberación de Medicamentos , Glioblastoma/tratamiento farmacológico , Hidrogeles/administración & dosificación , Animales , Antineoplásicos Alquilantes/química , Antineoplásicos Alquilantes/efectos de la radiación , Antineoplásicos Alquilantes/uso terapéutico , Apoptosis/efectos de los fármacos , Neoplasias Encefálicas/patología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Dacarbazina/administración & dosificación , Dacarbazina/química , Dacarbazina/efectos de la radiación , Dacarbazina/uso terapéutico , Preparaciones de Acción Retardada/administración & dosificación , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/efectos de la radiación , Preparaciones de Acción Retardada/uso terapéutico , Femenino , Glioblastoma/patología , Humanos , Hidrogeles/química , Hidrogeles/efectos de la radiación , Hidrogeles/uso terapéutico , Luz , Metacrilatos/química , Metacrilatos/efectos de la radiación , Ratones Desnudos , Microglía/efectos de los fármacos , Polietilenglicoles/química , Polietilenglicoles/efectos de la radiación , Temozolomida , Carga Tumoral/efectos de los fármacos
3.
J Med Chem ; 52(21): 6822-34, 2009 Nov 12.
Artículo en Inglés | MEDLINE | ID: mdl-19821576

RESUMEN

A series of metal complexes were prepared as potential prodrugs of the extremely toxic DNA minor groove alkylator 1-(chloromethyl)-5-hydroxy-3-[(5,6,7-trimethoxyindol-2-yl)carbonyl]-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) and close analogues. The pyrrolo[3,2-f]quinoline cytotoxins were prepared from 2-methoxy-4-nitroaniline in a nine-step synthesis involving a Skraup construction of a quinoline intermediate, its appropriate functionalization, and a final radical cyclization. The metal complexes were prepared from these and the labile metal complex synthons [Co(cyclen)(OTf)(2)](+), [Cr(acac)(2)(H(2)O)(2)](+), and [Co(2)(Me(2)dtc)(5)](+). The cobalt complexes were considerably more stable than the free effectors and showed significant attenuation of the cytotoxicity of the latter, with IC(50) ratios (complex/effector) of 50- to 150-fold, and substantial hypoxic cell selectivity, with IC(50) ratios (oxic/hypoxic cells) of 20- to 40-fold. The cobalt complexes were also efficiently activated by ionizing radiation, with G values for loss of the compound close to the theoretical value for one-electron reduction of 0.68 micromol/J. This work extends earlier observations that cobalt cyclen complexes are suitable for both the bioreductive and radiolytic release of potent pyrrolo[3,2-f]quinoline effectors.


Asunto(s)
Antineoplásicos Alquilantes/síntesis química , Cobalto , Complejos de Coordinación/síntesis química , Indoles/síntesis química , Profármacos/síntesis química , Pirroles/síntesis química , Quinolinas/síntesis química , Antineoplásicos Alquilantes/farmacología , Antineoplásicos Alquilantes/efectos de la radiación , Hipoxia de la Célula , Línea Celular Tumoral , Quelantes/síntesis química , Quelantes/química , Complejos de Coordinación/farmacología , Complejos de Coordinación/efectos de la radiación , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Indoles/farmacología , Indoles/efectos de la radiación , Oxidación-Reducción , Profármacos/farmacología , Profármacos/efectos de la radiación , Pirroles/farmacología , Pirroles/efectos de la radiación , Quinolinas/farmacología , Quinolinas/efectos de la radiación , Radiación Ionizante , Estereoisomerismo , Relación Estructura-Actividad
4.
Anticancer Drugs ; 20(8): 659-67, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19581798

RESUMEN

ZRBA1 is a molecule termed 'combi-molecule' designed to induce DNA-alkylating lesions and to block epidermal growth factor receptor (EGFR) tyrosine kinase. Owing to its ability to downregulate the EGFR tyrosine kinase-mediated antiapoptotic signaling and DNA repair proteins, we inferred that it could significantly sensitize cells to ionizing radiation. Using the MDA-MB-468 human breast cancer cell line in which ZRBA1 has already been reported to induce significant EGFR/DNA-targeting potency, the results showed that: (i) concurrent administration of ZRBA1 and 4 Gy radiation led to a significant decrease in cell viability, (ii) the greater efficacy of the combination was sequential, being limited to conditions wherein the drug was administered concurrently with radiation or before radiation, and (iii) the efficacy enhancement of the combination was further confirmed by clonogenic assays from which a dose enhancement factor of 1.34 could be observed at survival fraction of 0.01. Flow cytometric analysis showed significant enhancement of cell cycle arrest in G2/M (P<0.046, irradiated cells vs. cells treated with ZRBA1 and radiation) and increased apoptosis when ZRBA1 was combined with radiation. Likewise, significant levels of double-strand breaks were observed for the combination, as determined by neutral comet assay (P<0.045, irradiated cells vs. cells treated with ZRBA1 and radiation). These results in toto suggest that the superior efficacy of the ZRBA1 plus radiation combination may be secondary to the ability of ZRBA1 to arrest the cells in G2/M, a cell cycle phase in which tumor cells are sensitive to radiation. Furthermore, the increased levels of DNA damage, combined with the concomitant downregulation of EGFR-mediated signaling by ZRBA1, may account for the significant levels of cell killing induced by the combination.


Asunto(s)
Quinazolinas/farmacología , Fármacos Sensibilizantes a Radiaciones/farmacología , Triazenos/farmacología , Antineoplásicos/metabolismo , Antineoplásicos/farmacocinética , Antineoplásicos/farmacología , Antineoplásicos/efectos de la radiación , Antineoplásicos Alquilantes/metabolismo , Antineoplásicos Alquilantes/farmacocinética , Antineoplásicos Alquilantes/farmacología , Antineoplásicos Alquilantes/efectos de la radiación , Apoptosis/efectos de los fármacos , Apoptosis/efectos de la radiación , Ciclo Celular/efectos de los fármacos , Ciclo Celular/efectos de la radiación , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/efectos de la radiación , Daño del ADN/efectos de los fármacos , Daño del ADN/efectos de la radiación , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/metabolismo , Inhibidores Enzimáticos/farmacocinética , Inhibidores Enzimáticos/farmacología , Inhibidores Enzimáticos/efectos de la radiación , Receptores ErbB/antagonistas & inhibidores , Gefitinib , Humanos , Microscopía Fluorescente , Quinazolinas/metabolismo , Quinazolinas/farmacocinética , Quinazolinas/efectos de la radiación , Fármacos Sensibilizantes a Radiaciones/metabolismo , Fármacos Sensibilizantes a Radiaciones/farmacocinética , Fármacos Sensibilizantes a Radiaciones/efectos de la radiación , Triazenos/metabolismo , Triazenos/farmacocinética , Triazenos/efectos de la radiación , Ensayo de Tumor de Célula Madre , Rayos X
5.
Pharm Res ; 25(3): 598-604, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17710513

RESUMEN

PURPOSE: It has been reported that dacarbazine (DTIC) is photogenotoxic. The purpose of this study is to clarify the mechanism of photogenotoxicity induced by DTIC. MATERIALS AND METHODS: We examined DNA damage induced by UVA-irradiated DTIC using 32P-5'-end-labeled DNA fragments obtained from human genes. Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) in calf thymus DNA was measured by high performance liquid chromatograph with an electrochemical detector. Electron spin resonance (ESR) spin-trapping experiments were performed to detect radical species generated from UVA-irradiated DTIC. RESULTS: UVA-irradiated DTIC caused DNA damage at guanine residues, especially at the 5'-GGT-3' sequence in the presence of Cu(II) and also induced 8-oxodG generation in calf thymus DNA. DTIC-induced photodamage to DNA fragments was partially inhibited by catalase, whereas 8-oxodG formation was significantly increased by catalase. NaN3, a carbene scavenger, inhibited DNA damage and 8-oxodG formation in a dose-dependent manner, suggesting that carbene intermediates are involved. The ESR spin-trapping experiments demonstrated the generation of aryl radicals in the process of photodegradation of DTIC. CONCLUSION: Photoactivated DTIC generates the carbene and aryl radicals, which may induce both DNA adduct and 8-oxodG formation, resulting in photogenotoxicity. This study could provide an insight into the safe usage of DTIC.


Asunto(s)
Antineoplásicos Alquilantes/toxicidad , Daño del ADN , ADN/efectos de los fármacos , Dacarbazina/toxicidad , Mutágenos/toxicidad , Rayos Ultravioleta , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Antineoplásicos Alquilantes/química , Antineoplásicos Alquilantes/efectos de la radiación , Bovinos , Quelantes/farmacología , Cobre/química , ADN/química , Aductos de ADN , Dacarbazina/química , Dacarbazina/efectos de la radiación , Desoxiguanosina/análogos & derivados , Desoxiguanosina/química , Relación Dosis-Respuesta a Droga , Espectroscopía de Resonancia por Spin del Electrón , Depuradores de Radicales Libres/farmacología , Radicales Libres/química , Humanos , Estructura Molecular , Mutágenos/química , Mutágenos/efectos de la radiación , Conformación de Ácido Nucleico , Fenantrolinas/farmacología , Fotoquímica
6.
Tsitol Genet ; 37(4): 20-5, 2003.
Artículo en Ucraniano | MEDLINE | ID: mdl-14569619

RESUMEN

Analysis of chromosome instability (CI) is of great importance in view of pollution of the environment by genotoxic factors. Frequency of aberrant cells, spectrum of chromosome aberrations, damages of aberrant cell and distribution of aberrations in the cells are the most conventional parameters of CI. We have carried out the comparative analysis of the frequency of aberrant cells and the dynamics of aberrant cell damages induced by different mutagenic factors (alpha-irradiation from 241Am, gamma-irradiation from 60Co and tioTEPA) in Allium-test. This comparative analysis denotes that the studied parameters have different dynamics characterizing different mechanisms of CI in Allium cepa L.


Asunto(s)
Aberraciones Cromosómicas , Mutágenos , Allium/efectos de los fármacos , Allium/genética , Allium/efectos de la radiación , Partículas alfa/efectos adversos , Americio/toxicidad , Antineoplásicos Alquilantes/efectos de la radiación , Radioisótopos de Cobalto/efectos de la radiación , Relación Dosis-Respuesta a Droga , Relación Dosis-Respuesta en la Radiación , Rayos gamma/efectos adversos , Tiotepa/efectos de la radiación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...